Skip to content
The Nexus
DossierENTITY

Biovac

Coverage of Biovac in the Nexus archive.

Earliest in view: Jul 2 · 13:25 UTCMost recent: Jul 2 · 13:25 UTC
Co-mentioned in this coverage
Gaviorganization1Africa Centres for Disease Control and Preventionorganization1Shanelle Hallperson1African Unionorganization1International Finance Corporationorganization1European Investment Bankorganization1European Commissionorganization1
Recent coverage
  • HEALTHJul 2 · 13:25 UTCSEMAFOR
    Africa moves ahead with vaccine manufacturing ambitions

    Africa aims to produce 60% of its vaccines locally by 2040, supported by Gavi's $1.2 billion African Vaccine Manufacturing Accelerator. Initial disbursements to African manufacturers are expected in 2026, alongside efforts to secure technology transfer agreements and long-term funding for sustainable production.